SigmaGraft, Inc.

SigmaGraft is a FDA-cleared biomaterials company specializing in bone grafting and tissue regeneration products for dental and orthopedic applications. The company manufactures allograft, xenograft, and synthetic bioceramic bone substitutes, resorbable membranes for guided bone regeneration, and wound dressings. Key product lines include SigmaOss (allograft bone substitute available in multiple forms), InterOss (xenograft with collagen variants), BoneSigma (BCP and TCP formulations), AlloGen DBM (demineralized bone matrix for spine), and ExcellBone Active (for orthopedic applications). SigmaGraft collaborates with leading clinicians and researchers to develop and validate products for sinus augmentation, periodontal regeneration, and orthopedic trauma/sports medicine indications. Products are registered and sold internationally.